FDA clears Johnson & Johnson’s single-dose Covid-19 shot
WASHINGTON, DC — The U.S. now has a third vaccine to prevent Covid-19.
The Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
Health experts have anxiously awaited a one-and-done option to help speed vaccinations.
The virus has already killed more than 510,000 people in the U.S. and is mutating in increasingly worrisome ways.
The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death.
One dose was 85% protective against the most severe Covid-19 illness, in a massive study that spanned three continents.
RELATED CONTENT:
